← Back to Search

Meal Replacement

Group 2 for Protein Malnutrition (PDCAAS Trial)

Phase 4
Waitlist Available
Led By David C Voellinger, MD
Research Sponsored by Southeast Bariatrics, PA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

PDCAAS Trial Summary

The purpose of this research study is to compare the varying qualities of protein supplements utilizing the Protein Digestibility Corrected Amino Acid Score (PDCAAS) method and evaluating the clinical outcome related to protein stores and absorption.

PDCAAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Protein Absorption
Secondary outcome measures
Patient Compliance with Protein Supplement
Patient tolerability and satisfaction of protein supplement

PDCAAS Trial Design

3Treatment groups
Active Control
Group I: Group 2Active Control1 Intervention
full liquid diet utilizing protein supplements with PDCAAS of 0.5-0.99
Group II: Group 3Active Control1 Intervention
full liquid diet utilizing protein supplement with a PDCAAS less than 0.5
Group III: Group 1Active Control1 Intervention
full liquid diet utilizing meal replacements with PDCAAS of 1.0

Find a Location

Who is running the clinical trial?

Southeast Bariatrics, PALead Sponsor
University of North Carolina, CharlotteOTHER
23 Previous Clinical Trials
13,158 Total Patients Enrolled
David C Voellinger, MDPrincipal InvestigatorSoutheast Bariatrics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025